Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 1027-1032. doi: 10.19723/j.issn.1671-167X.2018.06.015
• Article • Previous Articles Next Articles
Ji LI1,2,Li ZHENG1,Lian-jie SHI2,Jing XU2,Jian-long SHU3,Xue-wu ZHANG3,△()
CLC Number:
[1] |
Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006,4(2):295-306.
doi: 10.1111/jth.2006.4.issue-2 |
[2] |
Pierangeli SS, Colden-Stanfield M, Liu X , et al. Antiphospholi-pid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo[J]. Circulation, 1999,99(15):1997-2002.
doi: 10.1161/01.CIR.99.15.1997 |
[3] |
Dunoyer-Geindre S, de Moerloose P, Galve-de Rochemonteix B , et al. NFκB is an essential intermediate in the activation of endothelial cells by anti-β2-glycoprotein 1 antibodies[J]. Thromb Haemost, 2002,88(5):851-857.
doi: 10.1055/s-0037-1613313 |
[4] |
Charakida M, Besler C, Batuca JR , et al. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome[J]. JAMA, 2009,302(11):1210-1217.
doi: 10.1001/jama.2009.1346 |
[5] |
Ames PR, Batuca JR, Ciampa A , et al. Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome[J]. J Rheumatol, 2010,37(12):2523-2530.
doi: 10.3899/jrheum.100494 pmid: 20889602 |
[6] |
Ramesh S, Morrell CN, Tarango C , et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2[J]. J Clin Invest, 2011,121(1):120-131.
doi: 10.1172/JCI39828 pmid: 3007129 |
[7] |
Toporsian M, Gros R, Kabir MG , et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia[J]. Circ Res, 2005,96(6):684-692.
doi: 10.1161/01.RES.0000159936.38601.22 pmid: 15718503 |
[8] |
Alt A, Miguel-Romero L, Donderis J , et al. Structural and functional insights into endoglin ligand recognition and binding[J]. PLoS One, 2012,7(2):e29948.
doi: 10.1371/journal.pone.0029948 pmid: 22347366 |
[9] |
Bernabeu C, Conley BA, Vary CP . Novel biochemical pathways of endoglin in vascular cell physiology[J]. J Cell Biochem, 2007,102(6):1375-1388.
doi: 10.1002/jcb.21594 pmid: 17975795 |
[10] |
Blazquez-Medela AM, Garcia-Ortiz L, Gomez-Marcos MA , et al. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients[J]. BMC Med, 2010,8:86.
doi: 10.1186/1741-7015-8-86 pmid: 21171985 |
[11] |
Strasky Z, Vecerova L, Rathouska J , et al. Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice[J]. Circ J, 2011,75(7):1747-1755.
doi: 10.1253/circj.CJ-10-1285 pmid: 21576826 |
[12] |
Vitverova B, Blazickova K, Najmanova I , et al. Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta[J]. Atherosclerosis, 2018,271:15-25.
doi: 10.1016/j.atherosclerosis.2018.02.008 pmid: 29459262 |
[13] |
Emeksiz HC, Bideci A, Damar Ç , et al. Soluble endoglin level increase occurs prior to development of subclinical structural vascular alterations in diabetic adolescents[J]. J Clin Res Pediatr Endocrinol, 2016,8(3):313-320.
doi: 10.4274/jcrpe |
[14] |
Rathouska J, Jezkova K, Nemeckova I , et al. Soluble endoglin, hypercholesterolemia and endothelial dysfunction[J]. Atherosclerosis, 2015,243(2):383-388.
doi: 10.1016/j.atherosclerosis.2015.10.003 pmid: 26520890 |
[15] |
Bassyouni IH, El-Shazly R, Azkalany GS , et al. Clinical significance of soluble-endoglin levels in systemic lupus erythematosus: possible association with anti-phospholipid syndrome[J]. Lupus, 2012,21(14):1565-1570.
doi: 10.1177/0961203312460115 pmid: 22941564 |
[16] |
Barbara NP, Wrana JL, Letarte M . Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily[J]. J Biol Chem, 1999,274(2):584-594.
doi: 10.1074/jbc.274.2.584 |
[17] |
Kapur NK, Wilson S, Yunis AA , et al. Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure[J]. Circulation, 2012,125(22):2728-2738.
doi: 10.1161/CIRCULATIONAHA.111.080002 |
[18] |
Venkatesha S, Toporsian M, Lam C , et al. Soluble endoglin contributes to the pathogenesis of preeclampsia[J]. Nat Med, 2006,12(6):642-649.
doi: 10.1038/nm1429 pmid: 16751767 |
[19] |
Chatterjee A, Black SM, Catravas JD . Endothelial nitric oxide (NO) and its pathophysiologic regulation[J]. Vascul Pharmacol, 2008,49(4/5/6):134-140.
doi: 10.1016/j.vph.2008.06.008 pmid: 2592563 |
[20] |
Palmer RM, Ferrige AG, Moncada S . Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J]. Nature, 1987,327(6122):524-526.
doi: 10.1038/327524a0 |
[21] |
de Caterina R, Libby P, Peng HB , et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines[J]. J Clin Invest, 1995,96(1):60-68.
doi: 10.1172/JCI118074 |
[22] |
Radomski MW, Palmer RM, Moncada S . Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium[J]. Lancet, 1987,2(8567):1057-1058.
doi: 10.1016/S0140-6736(87)91481-4 pmid: 2889967 |
[23] |
Lauer T, Preik M, Rassaf T , et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action[J]. Proc Natl Acad Sci USA, 2001,98(22):12814-12819.
doi: 10.1073/pnas.221381098 pmid: 11606734 |
[24] |
Robak E, Kierstan M, Cebula B , et al. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus[J]. Lupus, 2009,18(4):332-341.
doi: 10.1177/0961203308097572 pmid: 19276301 |
[25] |
Cervera R, Serrano R, Pons-Estel GJ , et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients[J]. Ann Rheum Dis, 2015,74(6):1011-1018.
doi: 10.1136/annrheumdis-2013-204838 pmid: 24464962 |
[26] |
Derksen RH, de Groot PG . The obstetric antiphospholipid syndrome[J]. J Reprod Immunol, 2008,77(1):41-50.
doi: 10.1016/j.jri.2006.12.003 |
[27] |
Holers VM, Girardi G, Mo L , et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss[J]. J Exp Med, 2002,195(2):211-220.
doi: 10.1084/jem.200116116 pmid: 11805148 |
[28] |
Soh MC, Pasupathy D, Gray G , et al. Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes[J]. Rheumatology(Oxford), 2013,52(9):1642-1647.
doi: 10.1093/rheumatology/ket173 pmid: 3741478 |
[29] |
Levine RJ, Lam C, Qian C , et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia[J]. N Eng J Med, 2006,355(10):992-1005.
doi: 10.1056/NEJMoa055352 pmid: 15805796 |
[1] | Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283. |
[2] | Li-rong HONG,Yu-jia CHEN,Qing-lai JIANG,Ru-lin JIA,Chun LI,Liang-hua FENG. Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1033-1038. |
[3] | Jin-man ZHUANG,Tian-run LI,Xuan LI,Jing-yuan LUAN,Chang-ming WANG,Qi-chen FENG,Jin-tao HAN. Application of Rotarex catheter system in femoropopliteal artery stenosis accompanied with thrombosis [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 328-332. |
[4] | Yu-ke HOU,Qing-meng CAI,Xiang-jun LIU,Ze-lin YUN,Chun LI,Xue-wu ZHANG. Clinical significance of oxidized low-density lipoprotein antibody in antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1117-1122. |
[5] | Rui LIU,Jin-xia ZHAO,Liang YAN. Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1079-1085. |
[6] | Yu-hua WANG,Guo-hua ZHANG,Ling-ling ZHANG,Jun-li LUO,Lan GAO. Adrenal hemorrhage in a patient with systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1178-1181. |
[7] | Jie-yu GU,Cui LU,Hui SHI,Cheng-de YANG. Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1033-1038. |
[8] | ZHENG Xiao-Juan, DENG Xiao-Li, LIU Xiang-Yuan. Pregnancy outcome in 54 patients with antiphospholipid syndrome:a retrospective clinical study [J]. Journal of Peking University(Health Sciences), 2014, 46(2): 323-328. |
|